Cardiotoxicity due to targeted anticancer agents: a growing challenge

di Shah, Chintan P., Moreb, Jan S.
Pubblicato in Ther Adv Cardiovasc Dis (2019)

Outcomes of Salvage Autologous Versus Allogeneic Hematopoietic Cell Transplantation for Relapsed Multiple Myeloma After Initial Autologous Hematopoietic Cell Transplantation

di Wirk, Baldeep, Byrne, Michael, Dai, Yunfeng, Moreb, Jan S.
Pubblicazione 2013

COVID-19 in patients with acute leukemia: Two cases with different outcomes

di Rajasurya, Venkat, Elliott, Kathleen, Dugan, James, Moreb, Jan S
Pubblicato in Leuk Res Rep (2020)

Combination of IFN-α/Gm-CSF as a Maintenance Therapy for Multiple Myeloma Patients After Autologous Stem Cell Transplantation (ASCT): A Prospective Phase II Study

di Salmasinia, Donya, Chang, Myron, Wingard, John R., Hou, Wei, Moreb, Jan S.
Pubblicazione 2010

Detection of Skeletal Lesions by Whole Body Multidetector Computed Tomography in Multiple Myeloma has no Impact on Long-Term Outcomes Post Autologous Hematopoietic Cell Transplanta...

di Wirk, Baldeep, Bush, Charles H., Hou, Wei, Pettiford, Leslie, Moreb, Jan S.
Pubblicato in World J Oncol (2012)

Long-Term Outcome after Autologous Stem Cell Transplantation with Adequate Peripheral Blood Stem Cell Mobilization Using Plerixafor and G-CSF in Poor Mobilizer Lymphoma and Myeloma...

di Moreb, Jan S., Salmasinia, Donya, Hsu, Jack, Hou, Wei, Cline, Christina, Rosenau, Emma
Pubblicazione 2011

Selective purging of human multiple myeloma cells from autologous stem cell transplant grafts using oncolytic myxoma virus

di Bartee, Eric, Chan, Winnie S., Moreb, Jan S., Cogle, Christopher R., McFadden, Grant
Pubblicazione 2012

Acute Lymphoblastic Leukemia following Lenalidomide Maintenance for Multiple Myeloma: Two Cases with Unexpected Presentation and Good Prognostic Features

di Khan, Abdullah M., Muzaffar, Jameel, Murthy, Hermant, Wingard, John R., Moreb, Jan S.
Pubblicato in Case Rep Hematol (2018)

Corrigendum to “Acute Lymphoblastic Leukemia following Lenalidomide Maintenance for Multiple Myeloma: Two Cases with Unexpected Presentation and Good Prognostic Features”

di Khan, Abdullah M., Muzaffar, Jameel, Murthy, Hemant, Wingard, John R., Moreb, Jan S.
Pubblicato in Case Rep Hematol (2019)

Efficacy and safety of carfilzomib in relapsed and/or refractory multiple myeloma: systematic review and meta-analysis of 14 trials

di Shah, Chintan, Bishnoi, Rohit, Wang, Yu, Zou, Fei, Bejjanki, Harini, Master, Samip, Moreb, Jan S.
Pubblicato in Oncotarget (2018)

Diverse T-cell differentiation potentials of human fetal thymus, fetal liver, cord blood and adult bone marrow CD34 cells on lentiviral Delta-like-1-modified mouse stromal cells

di Patel, Ekta, Wang, Bei, Lien, Lily, Wang, Yichen, Yang, Li-Jun, Moreb, Jan S, Chang, Lung-Ji
Pubblicazione 2009

The enzymatic activity of human aldehyde dehydrogenases 1A2 and 2 (ALDH1A2 and ALDH2) is detected by Aldefluor, inhibited by diethylaminobenzaldehyde and has significant effects on...

di Moreb, Jan S., Ucar, Deniz, Han, Shuhong, Amory, John K., Goldstein, Alex S., Ostmark, Blanca, Chang, Lung-Ji
Pubblicazione 2011

Myxoma and Vaccinia Viruses Bind Differentially to Human Leukocytes

di Chan, Winnie M., Bartee, Eric C., Moreb, Jan S., Dower, Ken, Connor, John H., McFadden, Grant
Pubblicazione 2013

ALDH isozymes downregulation affects cell growth, cell motility and gene expression in lung cancer cells

di Moreb, Jan S, Baker, Henry V, Chang, Lung-Ji, Amaya, Maria, Lopez, M Cecilia, Ostmark, Blanca, Chou, Wayne
Pubblicazione 2008

Regulation of in vitro human T cell development through interleukin-7 deprivation and anti-CD3 stimulation

di Patel, Ekta S, Okada, Starlyn, Hachey, Kevin, Yang, Li-jun, Durum, Scott K, Moreb, Jan S, Chang, Lung-Ji
Pubblicazione 2012

Ex vivo development, expansion and in vivo analysis of a novel lineage of dendritic cells from hematopoietic stem cells

di Han, Shuhong, Wang, Yichen, Wang, Bei, Patel, Ekta, Okada, Starlyn, Yang, Li-Jun, Moreb, Jan S, Chang, Lung-Ji
Pubblicazione 2010

Unanticipated Cardiotoxicity Associated with Targeted Anticancer Therapy in Patients with Hematologic Malignancies Patients: Natural History and Risk Factors

di Shah, Chintan, Gong, Yan, Szady, Anita, Sun, Qian, Pepine, Carl J., Langaee, Taimour, Lucas, Alexandra R., Moreb, Jan S.
Pubblicato in Cardiovasc Toxicol (2018)

Aldehyde dehydrogenase activity as a functional marker for lung cancer

di Ucar, Deniz, Cogle, Christopher R, Zucali, James R, Ostmark, Blanca, Scott, Edward W, Zori, Robert, Gray, Brian A, Moreb, Jan S
Pubblicazione 2008

Suppression of Spermatogenesis by Bisdichloroacetyldiamines Is Mediated by Inhibition of Testicular Retinoic Acid Biosynthesis

di Amory, John K., Muller, Charles H., Shimshoni, Jakob A., Isoherranen, Nina, Paik, Jisun, Moreb, Jan S., Amory, David W., Evanoff, Ryan, Goldstein, Alex S., Griswold, Michael D.
Pubblicazione 2010

Tandem Autologous Stem Cell Transplantation for Multiple Myeloma Patients Based on Response to Their First Transplant—A Prospective Phase II Study

di Byrne, Michael, Salmasinia, Donya, Leather, Helen, Cogle, Christopher R, Davis, Amy, Hsu, Jack W, Wiggins, Laura, Chang, Myron N, An, Qi, Wingard, John R, Moreb, Jan S
Pubblicazione 2014